Board Member
Alaunos Therapeutics, Inc. (TCRT)Equibles does not estimate personal net worth.
Get an email with a short summary when Alaunos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TCRT alertsKevin Boyle is recorded as CEO and Board Member at Alaunos Therapeutics, Inc. (TCRT). The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $392,500 for Kevin Boyle in fiscal 2024, including a base salary of $317,500. Disclosed compensation is on record for 3 fiscal years. Kevin Boyle has spoken on 4 earnings calls across 1 company, most recently for Alaunos Therapeutics, Inc. on August 15, 2022. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Heidi Hagen (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member) and 7 others.
“Apologies for the frog in my voice here; I think back to Mr. Rossi, my seventh and eighth-grade Latin teacher, and I remember the phrase, tempus fugit, time flies.”
“And welcome everyone to the Alaunos Therapeutics first quarter 2022 earnings call. Our team has been working diligently to advance our strategy of generating meaningful clinical progress and delivering shareholder value.”
“And welcome everyone to Alaunos Therapeutics' fourth quarter and full year 2021 earnings call. It has been just over six months since I joined the company, and in that time, we've made great strides advancing our novel TCRT program for the treatment of solid tumors.”
“And welcome everyone to ZIOPHARM's third quarter 2021 earnings call. When I joined ZIOPHARM just over two months ago, I promised to be transparent with shareholders and share my observations and perspectives at the next opportunity.”
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Alaunos Therapeutics, Inc. (TCRT) | Former Chief Executive Officer | $317,500 | $392,500 |
| 2022 | Alaunos Therapeutics, Inc. (TCRT) | Chief Executive Officer | $600,000 | $1,792,818 |
| 2021 | Alaunos Therapeutics, Inc. (TCRT) | Chief Executive Officer | $200,000 | $4,573,753 |
